FDA OKs Tafenoquine (Krintafel) to Prevent Malaria Relapse FDA OKs Tafenoquine (Krintafel) to Prevent Malaria Relapse

Tafenoquine is the first single-dose medicine to prevent the relapse of Plasmodium vivax malaria and marks a major contribution toward malaria eradication.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Alert Source Type: news